Fred Alger Management’s BioNTech BNTX Stock Holding History

Fred Alger Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,734	Closed	-$467K	–	469
2025 Q3	$467K	Sell	4,734 -9,105	-66%	-$974K	﹤0.01%	394
2025 Q2	$1.47M	Sell	13,839 -48,091	-78%	-$4.86M	0.01%	335
2025 Q1	$5.64M	Sell	61,930 -403,447	-87%	-$45.2M	0.03%	209
2024 Q4	$53M	Sell	465,377 -35,467	-7%	-$4.05M	0.25%	64
2024 Q3	$59.5M	Buy	+500,844	New	+$46M	0.29%	64
2023 Q1	–	Sell	-12,318	Closed	-$1.85M	–	527
2022 Q4	$1.85M	Buy	+12,318	New	+$1.9M	0.01%	348
2022 Q3	–	Sell	-149,164	Closed	-$22.2M	–	523
2022 Q2	$22.2M	Sell	149,164 -125,495	-46%	-$19.2M	0.1%	165
2022 Q1	$46.8M	Buy	+274,659	New	+$46.2M	0.15%	146
2020 Q4	–	Sell	-99,428	Closed	-$6.88M	–	474
2020 Q3	$6.88M	Buy	99,428 +89,428	+894%	+$6.42M	0.02%	225
2020 Q2	$667K	Buy	+10,000	New	+$499K	﹤0.01%	381

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fred Alger Management's BNTX Position: Q4 2025 in Review

Fred Alger Management sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 4,734 shares — an estimated $467K sold.

Fred Alger Management first reported a position in BNTX in Q2 2020 and held it in 10 quarters. The position peaked at $59.5M in Q3 2024. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

Fred Alger Management reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
Fred Alger Management sold 4,734 BioNTech shares in Q4 2025, an estimated $467K.
Fred Alger Management first reported a position in BioNTech in Q2 2020 and held it in 10 quarters.
Fred Alger Management's BioNTech position peaked at $59.5M in Q3 2024.
284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on Fred Alger Management's 13F filing for Q4 2025, filed 17 Feb 2026.